In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Glaukos brings in $29.5mm through its Series E round

Executive Summary

Glaukos Corp. (ophthalmic device for glaucoma) has raised $29.5mm through its Series E venture round. Meritech Capital Partners led the financing ($16mm) and was joined by current shareholders Versant Ventures, Domain Associates, Frazier Healthcare Ventures, InterWest Partners, Montreux Equity Partners, OrbiMed Advisors, and 11 other undisclosed investors.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies